Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review

INTRODUCTION: Bleeding is the most frequent complication in patients receiving venoarterial or venovenous extracorporeal membrane oxygenation (ECMO). Recombinant activated factor VII (rFVIIa) has been used in these patients with conflicting results. We describe our experience with rFVIIa for refract...

Descripción completa

Detalles Bibliográficos
Autores principales: Repessé, Xavier, Au, Siu Ming, Bréchot, Nicolas, Trouillet, Jean-Louis, Leprince, Pascal, Chastre, Jean, Combes, Alain, Luyt, Charles-Edouard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057417/
https://www.ncbi.nlm.nih.gov/pubmed/23531278
http://dx.doi.org/10.1186/cc12581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057417/
https://www.ncbi.nlm.nih.gov/pubmed/23531278
http://dx.doi.org/10.1186/cc12581

Ejemplares similares